Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Manuel Schmidt
Mode of Action of Maintenance Immunotherapy Therapy With the TLR-9 Agonist MGN1703 in Metastatic Colorectal Carcinoma: The Phase III IMPALA Study
Journal for ImmunoTherapy of Cancer
Oncology
Molecular Medicine
Pharmacology
Cancer Research
Allergy
Immunology
Wnt7a Counteracts Cancer Cachexia
Molecular Therapy - Oncolytics
Cancer Research
Oncology
Molecular Medicine
Pharmacology
Related publications
A Phase I/Ii Trial of TLR-7 Agonist Immunotherapy in Chronic Lymphocytic Leukemia
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
The Role of Capecitabine as Maintenance Therapy in De Novo Metastatic Nasopharyngeal Carcinoma: A Propensity Score Matching Study
Cancer Communications
Cancer Research
Oncology
Colorectal Cancer Genomic Biomarkers in the Clinical Management of Patients With Metastatic Colorectal Carcinoma
The Clinical Benefit of Bevacizumab in Metastatic Colorectal Cancer Is Independent of K-Ras Mutation Status: Analysis of a Phase III Study of Bevacizumab With Chemotherapy in Previously Untreated Metastatic Colorectal Cancer
Oncologist
Cancer Research
Medicine
Oncology
On the Verge: Immunotherapy for Colorectal Carcinoma
Journal of the National Comprehensive Cancer Network : JNCCN
Medicine
Oncology
Phase II Study of Gefitinib, Fluorouracil, Leucovorin, and Oxaliplatin Therapy in Previously Treated Patients With Metastatic Colorectal Cancer
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Immunotherapy of Melanoma: Efficacy and Mode of Action
JDDG - Journal of the German Society of Dermatology
Dermatology
A Multicenter Clinical Phase II Study of FOLFOXIRI Plus Bevacizumab as First-Line Therapy in Patients With Metastatic Colorectal Cancer: QUATTRO Study
Clinical Colorectal Cancer
Oncology
Gastroenterology
Baseline Carcinoembryonic Antigen as a Predictive Factor of Ramucirumab Efficacy in RAISE, a Second-Line Metastatic Colorectal Carcinoma Phase III Trial
European Journal of Cancer
Cancer Research
Oncology
